Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.

about

Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10.Hydroxycobalamin catalyzes the oxidation of diethyldithiocarbamate and increases its cytotoxicity independently of copper ions

P2860

Q55028385-250B1200-104D-41E2-9EE6-7E6BFC034A99 Q57070043-6AF262E9-0903-416E-8E30-1C69AA5920FC

P2860

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.

Item

http://www.wikidata.org/entity/Q41769991

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Anti-hepatocellular carcinoma ...... related kinase SNARK in vitro.

@en

type

Item

label

Anti-hepatocellular carcinoma ...... related kinase SNARK in vitro.

@en

prefLabel

Anti-hepatocellular carcinoma ...... related kinase SNARK in vitro.

@en

P1476

Anti-hepatocellular carcinoma ...... related kinase SNARK in vitro.

@en

P2093

Kaku Goto

http://www.w3.org/2001/XMLSchema#string

Naoya Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness

NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.

A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication

Evidence of cancer-promoting roles for AMPK and related kinases

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application

Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development

Drug repositioning: identifying and developing new uses for existing drugs

Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein.

Characterization of chemical libraries for luciferase inhibitory activity.

Kinase drug discovery--what's next in the field?

P304

74987-74999

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11820

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Raymond T Chung

P577

2016-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602492

http://www.w3.org/2001/XMLSchema#string

P921

alcoholism

P932

5342717

http://www.w3.org/2001/XMLSchema#string

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.

about

P2860

P2860

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932